One previous study showed that the pro-neurotrophin-NGFR signaling can induce neuron death through the JNK-p53 pathway (Aloyz et al., 1998), but little is known about if this is also true in cancer or if NGFR can activate p53 independent of its ligands. Here, NGFR is linked to cancer.